CoChat

Antimalarial drugs and pregnancy: safety, pharmacokinetics, and pharmacovigilance

Ward, Stephen A, Sevene, Esperanca JP, Hastings, Ian M, Nosten, François, McGready, Rose · 2007 · The Lancet Infectious Diseases
Cited by 159

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1473-3099(07)70025-7

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 56

  1. Tagbor, 2006, Efficacy, safety, and tolerability of amodiaquine plus sulphadoxine-pyrimethamine used alone or in combination for malaria treatment in pregnancy: a randomised trial, Lancet, 368, 1349, 10.1016/S0140-6736(06)69559-7 · DOI · Paper page
  2. Okoyeh, 1993, Sensitivity of Plasmodium falciparum to chloroquine in pregnant women in Zaria, northern Nigeria, Trop Geogr Med, 45, 56
  3. Rukaria-Kaumbutho, 1996, Resistance to chloroquine therapy in pregnant women with malaria parasitemia, Int J Gynaecol Obstet, 53, 235, 10.1016/0020-7292(96)02651-3 · DOI
  4. Mutabingwa, 1991, Chloroquine therapy still useful in the management of malaria during pregnancy in Muheza, Tanzania, Trop Geogr Med, 43, 131
  5. Nosten, 2006, Antimalarial drugs in pregnancy: a review, Curr Drug Saf, 1, 1, 10.2174/157488606775252584 · DOI · Paper page
  6. Hart, 1964, The ototoxicity of chloroquine phosphate, Arch Otolaryngol, 80, 407, 10.1001/archotol.1964.00750040419009 · doi:10.1001/archotol.1964.00750040419009
  7. Paufique, 1969, Retinal degeneration in 2 children following preventive antimalarial treatment of the mother during pregnancy, Bull Soc Ophtalmol Fr, 69, 466
  8. Parke, 1988, Antimalarial drugs and pregnancy, Am J Med, 84, 30, 10.1016/0002-9343(88)90359-2 · doi:10.1016/0002-9343(88)90359-2
  9. Costedoat-Chalumeau, 2003, Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group, Arthritis Rheum, 48, 3207, 10.1002/art.11304 · DOI · Paper page
  10. Okanlawon, 1993, Chloroquine-induced retardation of foetal lung maturation in rats, Afr J Med Med Sci, 22, 61
  11. Chatterjee, 1998, Comparative mutagenic and genotoxic effects of three antimalarial drugs, chloroquine, primaquine and amodiaquine, Mutagenesis, 29, 10
  12. Munzner, 1983, Mutagenicity testing of quinine with submammalian and mammalian systems, Toxicology, 26, 173, 10.1016/0300-483X(83)90068-9 · doi:10.1016/0300-483x(83)90068-9
  13. Savini, 1971, Experimental study of the effects of quinine on the rat, rabbit and dog fetus, Therapie, 26, 563
  14. Colley, 1989, Toxicity studies with quinine hydrochloride, Toxicology, 54, 219, 10.1016/0300-483X(89)90047-4 · DOI
  15. Tanimura, 1972, Effects on macaque embryos of drugs reported or suspected to be teratogenic to humans, Acta Endocrinol Suppl (Copenh), 166, 293
  16. Lapointe, 1979, Saccharin- or quinine-induced changes in the rat pups following prolonged ingestion by the dam, Biol Neonate, 36, 273, 10.1159/000241239 · DOI
  17. Nosten, 1999, The effects of mefloquine treatment in pregnancy, Clin Infect Dis, 28, 808, 10.1086/515183 · DOI
  18. Tsuda, 1998, Detection of pyrimethamine-induced DNA damage in mouse embryo and maternal organs by the modified alkaline single cell gel electrophoresis assay, Mutat Res, 415, 69, 10.1016/S1383-5718(98)00057-6 · doi:10.1016/s1383-5718(98)00057-6
  19. Chung, 1993, Synergistic embryotoxicity of combination pyrimethamine and folic acid in rats, Reprod Toxicol, 7, 463, 10.1016/0890-6238(93)90091-K · doi:10.1016/0890-6238(93)90091-k
  20. Keuter, 1990, Comparison of chloroquine, pyrimethamine and sulfadoxine, and chlorproguanil and dapsone as treatment for falciparum malaria in pregnant and non-pregnant women, Kakamega District, Kenya, BMJ, 301, 466, 10.1136/bmj.301.6750.466 · DOI
  21. Chen, 1984, Embryotoxicity and teratogenicity studies on artemether in mice, rats and rabbits, Zhongguo Yao Li Xue Bao, 5, 118
  22. Li, 1988, Teratogenicity of sodium artesunate, Zhong Yao Tong Bao, 13, 42
  23. Xu, 1996, Contragestational effects of dihydroartemisinin and artesunate, Yao Xue Xue Bao, 31, 657
  24. Clark, 2004, Developmental toxicity of artesunate and an artesunate combination in the rat and rabbit, Birth Defects Res A Clin Mol Teratol, 71, 380, 10.1002/bdrb.20027 · DOI · Paper page
  25. White, 2004, Developmental toxicity of artesunate in the rat and rabbit, Birth Defects Res A Clin Mol Teratol, 70, 265
  26. Jollie, 1990, Development, morphology, and function of the yolk-sac placenta of laboratory rodents, Teratology, 41, 361, 10.1002/tera.1420410403 · DOI · Paper page
  27. Kawamura, 1996, Histological changes in rat embryonic blood cells as a possible mechanism for ventricular septal defects produced by an N-phenylimide herbicide, Teratology, 54, 237, 10.1002/(SICI)1096-9926(199611)54:5<237::AID-TERA4>3.0.CO;2-X · doi:10.1002/(sici)1096-9926(199611)54:5<237::aid-tera4>3.0.co;2-x
  28. Longo, 2006, Effects of the antimalarial drug dihydroartemisinin (DHA) on rat embryos in vitro, Reprod Toxicol, 21, 83, 10.1016/j.reprotox.2005.05.005 · DOI
  29. Clark, 2006, Artesunate: embryolethal effects in cynomolgus monkeys, Am J Trop Med Hyg, 75, 54
  30. Brabin, 1993, A study of the consequences of malarial infection in pregnant women and their infants, Parasitologie, 35, 9
  31. Angus, 2002, Oral artesunate dose-response relationship in acute falciparum malaria, Antimicrob Agents Chemother, 46, 778, 10.1128/AAC.46.3.778-782.2002 · DOI
  32. Newton, 2000, Antimalarial bioavailability and disposition of artesunate in acute falciparum malaria, Antimicrob Agents Chemother, 44, 972, 10.1128/AAC.44.4.972-977.2000 · DOI · Paper page
  33. Hutagalung, 2005, A randomized trial of artemether-lumefantrine versus mefloquine-artesunate for the treatment of uncomplicated multi-drug resistant Plasmodium falciparum on the western border of Thailand, Malar J, 4, 46, 10.1186/1475-2875-4-46 · DOI · Paper page
  34. van Vugt, 1999, Absence of an interaction between artesunate and atovaquone-proguanil, Eur J Clin Pharmacol, 55, 469, 10.1007/s002280050658 · DOI
  35. Akintonwa, 1988, Placental and milk transfer of chloroquine in humans, Ther Drug Monit, 10, 147, 10.1097/00007691-198802000-00004 · DOI
  36. Massele, 1997, Chloroquine blood concentrations and malaria prophylaxis in Tanzanian women during the second and third trimesters of pregnancy, Eur J Clin Pharmacol, 52, 299, 10.1007/s002280050294 · DOI
  37. Chukwuani, 2004, Evidence for increased metabolism of chloroquine during the early third trimester of human pregnancy, Trop Med Int Health, 9, 601, 10.1111/j.1365-3156.2004.01227.x · doi:10.1111/j.1365-3156.2004.01227.x
  38. Fakeye, 2002, Therapeutic monitoring of chloroquine in pregnant women with malaria, West Afr J Med, 21, 286
  39. Nosten, 1990, Mefloquine antimalarial prophylaxis in pregnancy: dose finding and pharmacokinetic study, Br J Clin Pharmacol, 30, 79, 10.1111/j.1365-2125.1990.tb03746.x · DOI
  40. Na Bangchang, 1994, Mefloquine pharmacokinetics in pregnant women with acute falciparum malaria, Trans R Soc Trop Med Hyg, 88, 321, 10.1016/0035-9203(94)90101-5 · DOI · Paper page
  41. Phillips, 1986, Hypoglycaemia and antimalarial drugs: quinidine and release of insulin, Br J Clin Pharmacol, 21, 677, 10.1111/j.1365-2125.1986.tb05233.x · DOI · Paper page
  42. Wangboonskul, 1993, Single dose pharmacokinetics of proguanil and its metabolites in pregnancy, Eur J Clin Pharmacol, 44, 247, 10.1007/BF00271366 · DOI
  43. Alloueche, 2004, Comparison of chlorproguanil-dapsone with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in young African children: double-blind randomised controlled trial, Lancet, 363, 1843, 10.1016/S0140-6736(04)16350-2 · DOI
  44. Brabin, 2004, Dapsone therapy for malaria during pregnancy: maternal and fetal outcomes, Drug Saf, 27, 633, 10.2165/00002018-200427090-00002 · DOI
  45. Na-Bangchang, 2005, The pharmacokinetics and pharmacodynamics of atovaquone and proguanil for the treatment of uncomplicated falciparum malaria in third-trimester pregnant women, Eur J Clin Pharmacol, 61, 573, 10.1007/s00228-005-0969-7 · DOI
  46. Weinstein, 1976, Placental transfer of clindamycin and gentamicin in term pregnancy, Am J Obstet Gynecol, 124, 688, 10.1016/S0002-9378(16)33336-1 · DOI
  47. Ramsey, 2003, Maternal and transplacental pharmacokinetics of azithromycin, Am J Obstet Gynecol, 188, 714, 10.1067/mob.2003.141 · DOI
  48. Edwards, 2000, The management of adverse drug reactions: from diagnosis to signals, Adverse Drug Reactions J, 1, 103
  49. Sevene, 2005, System and market failures: the unavailability of magnesium sulphate for the treatment of eclampsia and pre-eclampsia in Mozambique and Zimbabwe, BMJ, 331, 765, 10.1136/bmj.331.7519.765 · DOI
  50. Simooya, 2005, The WHO ‘Roll Back Malaria Project’: planning for adverse event monitoring in Africa, Drug Saf, 28, 277, 10.2165/00002018-200528040-00001 · DOI
  51. Taylor, 2004, Antimalarial drug toxicity: a review, Drug Saf, 27, 25, 10.2165/00002018-200427010-00003 · DOI · Paper page
  52. Edwards, 1998, Safety monitoring of new anti-malarials in immediate post-marketing phase, Med Trop (Mars), 58, 93
  53. Dodoo, 2005, Effectiveness of a simplified spontaneous reporting form for intensive monitoring of adverse events during intermittent preventive treatment of malaria in pregnant women with sulphadoxine-pyrimethamine, Drug Saf, 28, 958
  54. Dodoo, 2005, Preliminary safety assessment of sulphadoxine-pyrimethamine during intermittent presumptive treatment of pregnant women in a region with high prevalence of G6PD deficiency, Int J Risk Saf Med, 17, 13, 10.3233/JRS-2005-329 · doi:10.3233/jrs-2005-329
  55. Beyens, 2003, Prescription of drugs to pregnant women in France: the HIMAGE study, Therapie, 58, 505, 10.2515/therapie:2003082 · DOI
  56. Gomes, 1999, Prevalence of use of medicines during pregnancy and its relationship to maternal factors, Rev Saude Publica, 33, 246, 10.1590/S0034-89101999000300005 · doi:10.1590/s0034-89101999000300005

Cited by

See all 159

Metadata

Authors
Ward, S. A., Sevene, E. J., Hastings, I. M., Nosten, F., & McGready, R.
Venue
The Lancet Infectious Diseases
Publisher
Elsevier BV
Published
2007-02
Volume
7
Issue
2
Pages
136-144
ISSN
1473-3099 (ISSN-L)
OpenAlex
W1987142506
Cited by
159
References
7
FWCI
17.29
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antimalarial drugs and pregnancy: safety, pharmacokinetics, and pharmacovigilance. https://app.cochat.ai/papers/10.1016/s1473-3099(07)70025-7
The paper
Ward, S. A., Sevene, E. J., Hastings, I. M., Nosten, F., & McGready, R. (2007). Antimalarial drugs and pregnancy: safety, pharmacokinetics, and pharmacovigilance. The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(07)70025-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.